You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
药明生物(02269.HK)吐5.5%曾低见86.55元 趁高折让逾8%配股兼大股东减持
阿思达克 11-01 09:54

药明生物(02269.HK)趁高折让逾8%配股兼大股东减持各筹逾39亿元,该股继昨天升至97.35元创逾16个月高位遇压後,今早最多回吐6.4%低见86.55元,现造87.45元,回吐5.5%,成交受公司配股上板带动急增至5,408万股,涉资46.15亿元。

药明生物以每股85元(较昨天收市价折让8.1%)向最少六名独立投资者配售4,650万股,集资净额约39.29亿元拟用作支持其疫苗和微生物产品开发及继续进行全球产能扩张。另外,公司大股东Biologics也与配售代理订立配售协议,拟以同价向独立第三方配股减持公司4,650万股,交易完成後,Biologics持股量将由45.68%降至40.44%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account